Drug recall · March 11, 2026
Product label: Temozolomide Capsules recall
Why: Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: Rising Pharmaceuticals, Inc., Allendale, NJ 07401, Country of origin: Taiwan, NDC 16571-816-51.
- Lots / codes
Lot #: 1TM0524003A, Exp. Date 09/2026.
- Quantity
- 1200 bottles
- Company
- Rising Pharma Holding, Inc., East Brunswick, NJ
- Distribution
- Nationwide within the U.S
- Initiated
- March 3, 2026 · Voluntary: Firm initiated
- Classified
- March 4, 2026
- Reported
- March 11, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Temozolomide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.